Sean P. Duffy, the Chief Executive Officer of Omada Health, Inc., has made notable stock transactions that include both acquisitions and dispositions of shares. These actions, reported in a recent SEC filing, highlight Duffy's ongoing engagement with the company's stock and may indicate strategic adjustments within the organization.

Omada Health, founded in Delaware, operates within the health services sector, focusing on digital health solutions. The company is known for its innovative approaches to chronic disease management and behavioral health. According to the latest SEC filing, Duffy executed these transactions on November 4, 2026, as part of a trading plan established earlier in the year.

The filing indicates that Duffy acquired 12,944 shares of Omada Health's common stock at a price of $5.82 per share. Additionally, he disposed of the same number of shares at a weighted average price of $19.2159, reflecting a significant profit on the transaction. Following these transactions, Duffy retains ownership of 395,538 shares directly and 103,651 shares through stock options.

“Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 13, 2026 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended,” the filing states.

These transactions may have implications for Omada Health's stakeholders, including investors and employees. Duffy's actions could signal confidence in the company's future prospects, potentially influencing investor sentiment. Additionally, the trading plan under which these transactions were executed suggests a structured approach to managing his stock holdings, which may be viewed positively by the market.

Looking ahead, the filing does not specify any further actions or upcoming events related to these transactions. However, Duffy's ongoing engagement with the company's stock will likely be monitored closely by investors and analysts as Omada Health continues to navigate the evolving landscape of the health services industry.